(Q37894236)

24 August 2017

1 reference

title

Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy? (English)

1 reference

24 August 2017

1 reference

Ian Fairweather

1

1 reference

24 August 2017

27 May 2011

1 reference

24 August 2017

Veterinary Parasitology

1 reference

24 August 2017

180

1 reference

24 August 2017

1-2

1 reference

24 August 2017

133-143

1 reference

Genetic variability among Fasciola hepatica samples from different host species and geographical localities in Spain revealed by the novel SRAP marker

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Dose-response inhibition of proteolytic activity by a cysteine protease inhibitor in a murine model of fasciolosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Effect of a cysteine protease inhibitor on Fasciola hepatica (liver fluke) fecundity, egg viability, parasite burden, and size in experimentally infected sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Role of ABC transporters in veterinary drug research and parasite resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Ketoconazole increases the plasma levels of ivermectin in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The sensitivity and specificity of two methods for detecting Fasciola infections in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Worm control and anthelmintic resistance: adventures with a model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Interaction between Fenbendazole and Piperonyl Butoxide: Pharmacokinetic and Pharmacodynamic Implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The use of bulk-tank milk ELISAs to assess the spatial distribution of Fasciola hepatica, Ostertagia ostertagi and Dictyocaulus viviparus in dairy cattle in Flanders (Belgium).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Lack of reversion in triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

A distinctive repertoire of cathepsins is expressed by juvenile invasive Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Associations between anti-Fasciola hepatica antibody levels in bulk-tank milk samples and production parameters in dairy herds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Qualitative and quantitative evaluation of coprological and serological techniques for the diagnosis of fasciolosis in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Activity of closantel against adult triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Cathepsin L1, the major protease involved in liver fluke (Fasciola hepatica) virulence: propetide cleavage sites and autoactivation of the zymogen secreted from gastrodermal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The major cathepsin L secreted by the invasive juvenile Fasciola hepatica prefers proline in the S2 subsite and can cleave collagen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Triclabendazole: new skills to unravel an old(ish) enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Triclabendazole progress report, 2005-2009: an advancement of learning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Liver fluke isolates: a question of provenance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciolicides: efficacy, actions, resistance and its management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Predicting impacts of climate change on Fasciola hepatica risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Excretory-secretory products of larval Fasciola hepatica investigated using a two-dimensional proteomic approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola hepatica: comparative effects of host resistance and parasite intra-specific interactions on size and reproductive histology in flukes from rats infected with isolates differing in triclabendazole sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Quantitative diagnosis of chronic fasciolosis. 2. The estimation of daily total egg production of Fasciola hepatica and the number of adult flukes in sheep by faecal egg counts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The kinetics of triclabendazole disposition in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Proteomic analysis of in vitro newly excysted juveniles from Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola antigens as vaccines against fascioliasis and schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Artesunate and artemether are effective fasciolicides in the rat model and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Efficacy, safety and pharmacokinetics of 1,2,4-trioxolane OZ78 against an experimental infection with Fasciola hepatica in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Sheep helminth parasitic disease in south eastern Scotland arising as a possible consequence of climate change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Influence on the antithyroid compound methimazole on the plasma disposition of fenbendazole and oxfendazole in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Cloning and expression of the major secreted cathepsin B-like protein from juvenile Fasciola hepatica and analysis of immunogenicity following liver fluke infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Metacercarial production of Lymnaea viridis experimentally infected with Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Interaction of macrocyclic lactones with the multidrug transporters: the bases of the pharmacokinetics of lipid-like drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Evolutionary origins, diversification, and biogeography of liver flukes (Digenea, Fasciolidae)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The importance of pH in regulating the function of the Fasciola hepatica cathepsin L1 cysteine protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The development of linear regression models using environmental variables to explain the spatial distribution of Fasciola hepatica infection in dairy herds in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Seroprevalence and spatial distribution of Fasciola hepatica-infected dairy herds in England and Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The silencing of cysteine proteases in Fasciola hepatica newly excysted juveniles using RNA interference reduces gut penetration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The anthelminthic agent albendazole does not interact with p-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

THE USE OF MM3 MONOCLONAL ANTIBODIES FOR THE EARLY IMMUNODIAGNOSIS OF OVINE FASCIOLIASIS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Field evaluation of the MM3-SERO ELISA for detection of anti-Fasciola IgG antibodies in milk samples from individual cows and bulk milk tanks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Resistance of Fasciola hepatica to triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Performance characteristics of an enzyme-linked immunosorbent assay for the detection of liver fluke (Fasciola hepatica) infection in sheep and cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Development of functional genomic tools in trematodes: RNA interference and luciferase reporter gene activity in Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Proteomics and phylogenetic analysis of the cathepsin L protease family of the helminth pathogen Fasciola hepatica: expansion of a repertoire of virulence-associated factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Development of an antibody-detection ELISA for Fasciola hepatica and its evaluation against a commercially available test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Prevalence of Fasciola hepatica in dairy herds in England and Wales measured with an ELISA applied to bulk-tank milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to Fasciola hepatica in milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Changes to oxfendazole chiral kinetics and anthelmintic efficacy induced by piperonyl butoxide in horses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Managing parasiticide resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Diagnosis and economic consequences of triclabendazole resistance in Fasciola hepatica in a sheep flock in south-east Scotland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Genetic differentiation in eastern European and western Asian populations of the liver fluke, Fasciola hepatica, as revealed by mitochondrial nad1 and cox1 genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

A single amino acid substitution affects substrate specificity in cysteine proteinases from Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Cathepsin B proteases of flukes: the key to facilitating parasite control?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

The major secreted cathepsin L1 protease of the liver fluke, Fasciola hepatica: a Leu-12 to Pro-12 replacement in the nonconserved C-terminal region of the prosegment prevents complete enzyme autoactivation and allows definition of the molecular eve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Structural and Functional Relationships in the Virulence-associated Cathepsin L Proteases of the Parasitic Liver Fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Genetic diversity of liver flukes (Fasciola hepatica) from Eastern Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

[Does 2003 summer heat wave modified prevalence of bovine helminthosis in southwestern France?].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Fasciola hepatica: time-dependent disruption of spermatogenesis following in vivo treatment with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Climate change and infectious disease: helminthological challenges to farmed ruminants in temperate regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Allozyme markers suitable for population genetic analysis of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Treatment vs non-treatment of helminth infections in cattle: defining the threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Evidence for multiple mitochondrial lineages of Fasciola hepatica (liver fluke) within infrapopulations from cattle and sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Population dynamics of the liver fluke, Fasciola hepatica: the effect of time and spatial separation on the genetic diversity of fluke populations in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Potential role of hares in the spread of liver fluke in the Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Drug resistance in veterinary helminths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

Elucidating the transcriptome of Fasciola hepatica - a key to fundamental and biotechnological discoveries for a neglected parasite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

A portrait of the transcriptome of the neglected trematode, Fasciola gigantica--biological and biotechnological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.034

10.1016/J.VETPAR.2011.05.034

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21703766